Inactive Instrument
Eurofins-Cerep Share Price Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 82.22M 93.57M 76.74M 70.43M 132M 8.96B 135M 910M 356M 4.43B 351M 344M 15.33B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 61.18M 69.63M 57.11M 52.41M 98.11M 6.67B 101M 677M 265M 3.3B 261M 256M 11.41B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 93.68M | |
| +2.61% | +7.16% | -0.93% | +13.78% | 47.88B | |
| -0.03% | -0.52% | +391.98% | +593.64% | 39.09B | |
| -0.29% | +2.93% | +7.71% | +53.73% | 36.75B | |
| +1.41% | +23.96% | +26.49% | +9.97% | 40.55B | |
| +1.47% | +4.90% | +6.48% | +43.52% | 27.96B | |
| -0.13% | +0.81% | - | - | 16.77B | |
| +3.06% | +11.13% | +31.03% | +131.83% | 15.94B | |
| +0.18% | -2.75% | +3.22% | +9.68% | 13.55B | |
| +0.58% | +8.90% | -1.64% | -27.54% | 13.81B | |
| Average | +0.82% | +4.66% | +58.04% | +103.58% | 28.03B | |
| Weighted average by Cap. | +0.93% | +5.06% | +73.59% | +124.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.08M 37.79M 34.68M 64.93M 4.41B 66.53M 448M 175M 2.18B 173M 169M 7.55B | 41.1M 46.77M 38.36M 35.21M 65.9M 4.48B 67.53M 455M 178M 2.22B 176M 172M 7.66B |
| Net income | 7.15M 8.14M 6.68M 6.13M 11.47M 780M 11.76M 79.19M 30.97M 386M 30.57M 29.91M 1.33B | 4.78M 5.44M 4.46M 4.1M 7.67M 521M 7.86M 52.94M 20.7M 258M 20.43M 19.99M 892M |
| Net Debt | -17.25M -19.63M -16.1M -14.78M -27.67M -1.88B -28.35M -191M -74.68M -931M -73.72M -72.12M -3.22B | -21.03M -23.94M -19.63M -18.02M -33.73M -2.29B -34.56M -233M -91.05M -1.13B -89.88M -87.93M -3.92B |
Employees
-
